Treatment of metastatic hypernephroma.
D000230:Adenocarcinoma / Q000000981:diagnostic imaging / Q000188:drug therapy / Q000401:mortality / Q000628:therapy*; D000305:Adrenal Cortex Hormones; D000328:Adult; D000368:Aged; D000728:Androgens / Q000627:therapeutic use; D001859:Bone Neoplasms / Q000628:therapy; D005004:Ethmoid Bone; D005260:Female; D006801:Humans; D007680:Kidney Neoplasms / Q000188:drug therapy / Q000401:mortality / Q000532:radiotherapy / Q000628:therapy*; D008175:Lung Neoplasms / Q000628:therapy; D008207:Lymphatic Metastasis / Q000628:therapy; D008297:Male; D008824:Michigan; D008875:Middle Aged; D009362:Neoplasm Metastasis / Q000188:drug therapy / Q000532:radiotherapy / Q000628:therapy*; D011372:Progestins / Q000627:therapeutic use; D011859:Radiography; D012189:Retrospective Studies; D013964:Thyroid Neoplasms / Q000628:therapy; D013997:Time Factors
D000305:Adrenal Cortex Hormones; D000728:Androgens; D011372:Progestins